Dr Reddy’s Laboratories Ltd has launched Esomeprazole Magnesium Delayed-Release Capsules in the US market. This is an over-the-counter (OTC) therapeutic equivalent generic version of Nexium capsules.
Esomeprazole Magnesium Delayed-Release Capsules is an OTC proton pump inhibitor used to treat frequent heartburn occurring two or more days in a week in adults.
"This launch continues to demonstrate our R&D and manufacturing capabilities to bring newer store-brand OTC medications to the market,” Milan Kalawadia, Vice President and Head, US OTC and Speciality Rx businesses, Dr. Reddy’s Laboratories, said in a release.
The combined market of Nexium capsules and private label OTC Esomeprazole Magnesium products had US sales of approximately $311 million for the most recent 12 months ended May 2018, according to IRI.
The company shares were trading up by 1.71 per cent at Rs 2,065.65 on the BSE.